Log In
BCIQ
Print this Print this
 

VEGFR2

  Manage Alerts
Collapse Summary General Information
Company AB Science S.A.
DescriptionVascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2)
Molecular Target Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)
Mechanism of ActionVascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationRenal cancer
Indication DetailsTreat renal cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today